Latest On HTG Molecular Diagnostics, Inc (HTGM):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-11 05:36 EST | News | HTG Molecular GAAP EPS of -$2.28 misses by $0.34, revenue of $1.03M misses by $0.57M | N/A |  |
| 2023-01-06 12:47 EST | News | HTG Molecular Diagnostics expects FY22 revenue above consensus | N/A | |
| 2022-12-27 22:52 EST | News | AMRS, TTM and OMER among premarket gainers | N/A | |
| 2022-12-27 22:52 EST | News | HTG Molecular surges ~30% on closing $10M stock, warrants offering | N/A | |
| 2022-12-21 23:01 EST | News | HTG Molecular stock dips after pricing $10M securities offering | N/A | |
| 2022-12-21 06:01 EST | News | HTG surges 88% on one-for-twelve reverse stock split | N/A | |
| 2022-11-11 11:17 EST | News | HTG Molecular GAAP EPS of -$0.41 beats by $0.13, revenue of $1.25M misses by $1.58M | N/A | |
| 2022-08-12 03:34 EST | News | HTG Molecular Q2 GAAP loss per share widens, revenue down | N/A | |
| 2022-08-12 03:34 EST | News | HTG Molecular Diagnostics, Inc. (HTGM) CEO John Lubniewski on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-08-10 17:57 EST | News | HTG Molecular Q2 2022 Earnings Preview | N/A | |
| 2022-07-18 12:59 EST | News | HTG Molecular Diagnostics amends senior loan facility | N/A | |
| 2022-05-13 16:40 EST | News | HTG Molecular Diagnostics, Inc. (HTGM) CEO John Lubniewski on Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2022-05-12 18:27 EST | News | HTG Molecular GAAP EPS of -$0.81, revenue of $1.18M | N/A | |
| 2022-05-12 00:18 EST | News | HTG Molecular Q1 2022 Earnings Preview | N/A | |
| 2022-03-30 02:32 EST | News | HTG Molecular GAAP EPS of -$2.47 misses by $0.10, revenue of $8.91M in-line | N/A | |
| 2022-03-30 02:32 EST | News | HTG Molecular Diagnostics, Inc. (HTGM) CEO John Lubniewski on Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2022-03-29 01:25 EST | News | HTG Molecular FY 2021 Earnings Preview | N/A | |
| 2022-03-18 21:42 EST | News | HTG Molecular Diagnostics slips on $7.5M private placement | N/A | |
| 2022-01-07 22:25 EST | News | HTG Molecular Diagnostics expects FY21 revenue of ~$8.9M; slightly above consensus | N/A | |
| 2021-11-26 18:10 EST | News | Warning: HTGM is at high risk of performing badly | N/A | |
| 2021-11-11 07:11 EST | News | HTG Molecular EPS beats by $0.04, misses on revenue | N/A | |
| 2021-11-11 07:11 EST | News | HTG Molecular Diagnostics' (HTGM) CEO John Lubniewski on Q3 2021 Results - Earnings Call Transcript | N/A | |
| 2021-11-10 09:31 EST | News | HTG Molecular Q3 2021 Earnings Preview | N/A | |
| 2021-08-13 14:44 EST | News | HTG Molecular Diagnostics, Inc. (HTGM) CEO John Lubniewski on Q2 2021 Results - Earnings Call Transcript | N/A | |
| 2021-08-12 18:24 EST | News | HTG Molecular EPS beats by $0.36, misses on revenue | N/A | |
| 2021-07-21 11:28 EST | News | HTG Molecular completes product design lock for planned transcriptome panel | N/A | |
| 2021-03-26 10:10 EST | News | HTG Molecular EPS misses by $1.15, beats on revenue | N/A | |
| 2021-03-26 10:10 EST | News | HTG Molecular Diagnostics, Inc. (HTGM) CEO John Lubniewski on Q4 2020 Results - Earnings Call Transcript | N/A | |
| 2021-01-05 16:22 EST | News | HTG shares surge after upbeat 2020 revenue forecast | N/A | |
| 2020-12-01 12:11 EST | Analyst Rating | The Analyst Target Price has decreased from $14.63 to $12.75. | Neutral | |
| 2020-11-26 20:20 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-24 12:20 EST | Analyst Rating | The Analyst Target Price has increased from $0.98 to $14.63. | Buy | |
| 2020-11-24 00:07 EST | Stock Split | A stock split has occured on Nov 23, 2020 with a split factor of 1:15. | Neutral | |
| 2020-11-23 19:30 EST | News | HTG Molecular Diagnostics announced 1:15 reverse stock split | N/A | |
| 2020-11-18 15:58 EST | News | HTG Molecular Diagnostics (HTGM) Investor Presentation - Slideshow | N/A | |
| 2020-11-17 04:18 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-13 04:32 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-12 04:11 EST | Analyst Rating | The Analyst Target Price has decreased from $1.02 to $0.98. | Neutral | |
| 2020-11-11 21:12 EST | News | HTG Molecular EPS beats by $0.01, misses on revenue | N/A | |
| 2020-11-11 21:11 EST | News | HTG Molecular Diagnostics, Inc. (HTGM) CEO John Lubniewski on Q3 2020 Results - Earnings Call Transcript | N/A | |
| 2020-11-11 04:08 EST | Earnings Estimate | An EPS average of -$0.06 is estimated for the quarter ending on March 31, 2021. | Buy | |
| 2020-11-11 04:08 EST | Analyst Rating | The Analyst Target Price has decreased from $1.27 to $1.02. | Neutral | |
| 2020-11-07 16:06 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-26 13:02 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-17 05:09 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-18 08:54 EST | Analyst Rating | The Analyst Target Price has decreased from $1.3 to $1.27. | Neutral | |
| 2020-08-14 09:06 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-13 05:00 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-12 17:38 EST | News | HTG Molecular EPS in-line, beats on revenue | N/A | |
| 2020-08-12 17:37 EST | News | HTG Molecular Diagnostics' (HTGM) CEO John Lubniewski on Q2 2020 Results - Earnings Call Transcript | N/A | |
About HTG Molecular Diagnostics, Inc (HTGM):
HTG Molecular Diagnostics, Inc. a commercial stage life sciences company, focuses on the precision medicine. The company offers instrumentation; consumables comprising assay kits; and software that automate sample processing and profiles various molecular targets. Its platforms generate a molecular profiling library for detection using next-generation sequencing. The company's marketed panels include HTG EdgeSeq oncology biomarker panel; HTG EdgeSeq immuno-oncology assay; HTG EdgeSeq DLBCL cell of origin assay; HTG EdgeSeq path assay; HTG EdgeSeq miRNA whole-transcriptome assay; HTG EdgeSeq DLBCL cell of origin assay EU; HTG EdgeSeq ALKPlus assay EU;HTG EdgeSeq precision immuno-oncology panel; HTG lung fusions assay; HTG autoimmune panel; and HTG mouse mRNA tumor response panel. It serves biopharmaceutical companies, academic research centers, and molecular testing laboratories. HTG Molecular Diagnostics, Inc. distributes its instruments and consumables directly in the United States and Europe; and through distributors in parts of Europe and internationally. The company has a governing agreement with QIAGEN Manchester Limited; and an agreement with Illumina, Inc. for the development of nuclease-protection-based RNA or DNA profiling tests. The company was formerly known as HTG, Inc. and changed its name to HTG Molecular Diagnostics, Inc. in March 2011. HTG Molecular Diagnostics, Inc. was incorporated in 1997 and is based in Tucson, Arizona.
General
- Name HTG Molecular Diagnostics, Inc
- Symbol HTGM
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryDiagnostics & Research
- Full Time Employees 108
- Last Split Factor1:15
- Last Split Date2020-11-23
- Fiscal Year EndDecember
- IPO Date2015-05-06
- Gic SectorHealth Care
- Gic GroupHealth Care Equipment & Services
- Gic IndustryHealth Care Technology
- Gic SubIndustryHealth Care Technology
- Web URLhttp://www.htgmolecular.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 2.43
- Price/Book (Most Recent Quarter) 1.73
- Enterprise Value Revenue 0.78
- Enterprise Value EBITDA 0.02
View More
Financials
- Most Recent Quarter 2020-09-30
- Next Quarter EPS Estimate -$0.07
- Profit Margin -195%
- Operating Margin -185%
- Return on Assets -28%
- Return on Equity -95%
- Revenue 10.77 million
- Earnings Per Share -$0.60
- Revenue Per Share $2.42
- Gross Profit -277709
- Quarterly Earnings Growth -67.1%
View More
Highlights
- Market Capitalization 28.41 million
- EBITDA -15601510
- Analyst Target Price $12.75
- Book Value Per Share $2.28
View More
Share Statistics
- Shares Outstanding 4.74 million
- Shares Float 3.02 million
- % Held by Insiders 505%
- % Held by Institutions 33.14%
- Shares Short 23448
- Shares Short Prior Month 39414
- Short Ratio 0.15
- Short % of Float 1%
View More
Technicals
- Beta 1.41
- 52 Week High $13.8
- 52 Week Low $3.78
- 50 Day Moving Average 6.46
- 200 Day Moving Average 5.47
View More
Dividends
- Dividend Date 2020-11-23
- ExDividend Date N/A
- Dividend Yield 0%
View More
HTG Molecular Diagnostics, Inc (HTGM) Dividend Calendar:
HTGM's last dividend payment was made to shareholders on November 23, 2020.
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
HTG Molecular Diagnostics, Inc (HTGM) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-09-30 | 2020-11-10 | $N/A | -$1.05 | -$1.05 | 0% |
| 2020-06-30 | 2020-08-11 | $N/A | -$1.18 | -$1.25 | 5.32% |
| 2020-03-31 | 2020-05-13 | $2.23 million | -$1.20 | -$1.05 | -14.29% |
| 2019-12-31 | 2020-03-25 | $4.8 million | -$0.15 | -$1.45 | 89.66% |
| 2019-09-30 | 2019-11-12 | $5.4 million | -$2.25 | -$2.48 | 9.09% |
| 2019-06-30 | 2019-08-06 | $5.8 million | -$2.55 | -$2.29 | -11.48% |
| 2019-03-31 | 2019-05-09 | $3.2 million | -$2.85 | -$2.93 | 2.56% |
| 2018-12-31 | 2019-03-07 | $7.73 million | -$1.05 | -$2.66 | 60.56% |
| 2018-09-30 | 2018-11-08 | $4.71 million | -$2.55 | -$2.85 | 10.53% |
| 2018-06-30 | 2018-08-07 | $4.91 million | -$2.10 | -$3.00 | 30% |
| 2018-03-31 | 2018-05-10 | $4.16 million | -$3.20 | -$3.83 | 16.27% |
| 2017-12-31 | 2018-03-22 | $7.9 million | -$2.25 | -$4.58 | 50.82% |
| 2017-09-30 | 2017-11-07 | $3.72 million | -$6.90 | -$7.80 | 11.54% |
| 2017-06-30 | 2017-08-08 | $1.76 million | -$9.00 | -$8.63 | -4.35% |
| 2017-03-31 | 2017-05-15 | $1.37 million | -$10.95 | -$10.50 | -4.29% |
| 2016-12-31 | 2017-03-23 | $1.46 million | -$11.40 | -$11.40 | 0% |
| 2016-09-30 | 2016-11-14 | $914000 | -$13.80 | -$12.68 | -8.88% |
| 2016-06-30 | 2016-08-09 | $1.9 million | -$14.70 | -$14.25 | -3.16% |
| 2016-03-31 | 2016-05-12 | $865000 | -$15.30 | -$12.30 | -24.39% |
| 2015-12-31 | 2016-03-25 | $1.22 million | -$7.05 | -$11.93 | 40.88% |
| 2015-09-30 | 2015-11-12 | $1.01 million | -$0.76 | -$0.85 | 10.59% |
| 2015-06-30 | 2015-08-06 | $791000 | -$1.73 | -$0.70 | -147.14% |
| 2015-03-31 | 2015-05-06 | $1.02 million | -$0.73 |
HTG Molecular Diagnostics, Inc (HTGM) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
HTG Molecular Diagnostics, Inc (HTGM) Chart:
HTG Molecular Diagnostics, Inc (HTGM) News:
Below you will find a list of latest news for HTG Molecular Diagnostics, Inc (HTGM) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
HTG Molecular Diagnostics, Inc (HTGM) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Latest HTGM Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 6:56 PM EST | 3 | $0.5021 |
| Jun 13, 2022 7:40 PM EST | 2 | $0.5021 |
| Jun 13, 2022 7:53 PM EST | 1 | $0.5021 |
| Jun 13, 2022 7:55 PM EST | 1 | $0.5021 |
| Jun 13, 2022 7:57 PM EST | 1 | $0.5021 |
HTG Molecular Diagnostics, Inc (HTGM) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919120040531/0001209191-20-040531-index.htm |
| 2019-02-08 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1169987/000000000019001540/0000000000-19-001540-index.htm |
| 2019-10-21 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1169987/000000000019014741/0000000000-19-014741-index.htm |
| 2019-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1169987/000008025519002693/0000080255-19-002693-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1169987/000008025520001290/0000080255-20-001290-index.htm |
| 2019-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1169987/000031506619001107/0000315066-19-001107-index.htm |
| 2019-10-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1169987/000031506619001723/0000315066-19-001723-index.htm |
| 2020-02-04 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1169987/000089016320000005/0000890163-20-000005-index.htm |
| 2019-09-30 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1169987/000091957419006115/0000919574-19-006115-index.htm |
| 2020-01-31 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1169987/000091957420000672/0000919574-20-000672-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1169987/000091957420001178/0000919574-20-001178-index.htm |
| 2019-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1169987/000093583619000100/0000935836-19-000100-index.htm |
| 2019-09-30 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1169987/000093583619000506/0000935836-19-000506-index.htm |
| 2020-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1169987/000093583620000113/0000935836-20-000113-index.htm |
| 2020-02-27 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1169987/000093583620000172/0000935836-20-000172-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1169987/000110465919008623/0001104659-19-008623-index.htm |
| 2020-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1169987/000110465920021224/0001104659-20-021224-index.htm |
| 2019-07-01 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1169987/000110580619000018/0001105806-19-000018-index.htm |
| 2020-03-20 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1169987/000110580620000016/0001105806-20-000016-index.htm |
| 2019-10-01 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1169987/000116998719000002/0001169987-19-000002-index.htm |
| 2018-12-27 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1169987/000119312518359229/0001193125-18-359229-index.htm |
| 2019-01-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1169987/000119312519009042/0001193125-19-009042-index.htm |
| 2019-02-07 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1169987/000119312519030954/0001193125-19-030954-index.htm |
| 2019-03-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1169987/000119312519073298/0001193125-19-073298-index.htm |
| 2019-03-13 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1169987/000119312519073308/0001193125-19-073308-index.htm |
| 2019-07-03 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1169987/000119312519188445/0001193125-19-188445-index.htm |
| 2019-09-19 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1169987/000119312519249544/0001193125-19-249544-index.htm |
| 2019-09-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1169987/000119312519249550/0001193125-19-249550-index.htm |
| 2019-09-23 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1169987/000119312519252310/0001193125-19-252310-index.htm |
| 2019-09-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1169987/000119312519252336/0001193125-19-252336-index.htm |
| 2019-09-27 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1169987/000119312519257619/0001193125-19-257619-index.htm |
| 2019-10-11 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1169987/000119312519266729/0001193125-19-266729-index.htm |
| 2019-11-12 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1169987/000119312519290049/0001193125-19-290049-index.htm |
| 2019-11-15 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1169987/000119312519292582/0001193125-19-292582-index.htm |
| 2019-11-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1169987/000119312519292584/0001193125-19-292584-index.htm |
| 2019-11-22 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1169987/000119312519298748/0001193125-19-298748-index.htm |
| 2020-05-27 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1169987/000119312520151776/0001193125-20-151776-index.htm |
| 2018-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919118053334/0001209191-18-053334-index.htm |
| 2018-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919118053342/0001209191-18-053342-index.htm |
| 2018-12-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919118062945/0001209191-18-062945-index.htm |
| 2018-12-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919118062946/0001209191-18-062946-index.htm |
| 2018-12-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919118062947/0001209191-18-062947-index.htm |
| 2019-01-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919119000593/0001209191-19-000593-index.htm |
| 2019-01-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919119000594/0001209191-19-000594-index.htm |
| 2019-01-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919119000595/0001209191-19-000595-index.htm |
| 2019-04-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919119022078/0001209191-19-022078-index.htm |
| 2019-04-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919119022081/0001209191-19-022081-index.htm |
| 2019-04-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919119022089/0001209191-19-022089-index.htm |
| 2019-05-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919119032676/0001209191-19-032676-index.htm |
| 2019-05-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919119033217/0001209191-19-033217-index.htm |
| 2019-05-29 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919119033222/0001209191-19-033222-index.htm |
| 2019-06-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919119036610/0001209191-19-036610-index.htm |
| 2019-06-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919119036611/0001209191-19-036611-index.htm |
| 2019-06-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919119036612/0001209191-19-036612-index.htm |
| 2019-07-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919119041078/0001209191-19-041078-index.htm |
| 2019-07-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919119041082/0001209191-19-041082-index.htm |
| 2019-07-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919119041086/0001209191-19-041086-index.htm |
| 2019-08-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919119046316/0001209191-19-046316-index.htm |
| 2019-08-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919119046320/0001209191-19-046320-index.htm |
| 2019-08-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919119046323/0001209191-19-046323-index.htm |
| 2019-08-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919119046327/0001209191-19-046327-index.htm |
| 2019-08-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919119046332/0001209191-19-046332-index.htm |
| 2019-08-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919119046334/0001209191-19-046334-index.htm |
| 2019-08-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919119046648/0001209191-19-046648-index.htm |
| 2019-08-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919119046652/0001209191-19-046652-index.htm |
| 2019-08-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919119046653/0001209191-19-046653-index.htm |
| 2019-09-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919119049649/0001209191-19-049649-index.htm |
| 2019-09-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919119049655/0001209191-19-049655-index.htm |
| 2019-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919119051685/0001209191-19-051685-index.htm |
| 2019-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919119051695/0001209191-19-051695-index.htm |
| 2019-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919119051702/0001209191-19-051702-index.htm |
| 2019-11-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919119056935/0001209191-19-056935-index.htm |
| 2019-12-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919119060253/0001209191-19-060253-index.htm |
| 2019-12-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919119060257/0001209191-19-060257-index.htm |
| 2019-12-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919119060261/0001209191-19-060261-index.htm |
| 2020-01-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919120000350/0001209191-20-000350-index.htm |
| 2020-01-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919120000353/0001209191-20-000353-index.htm |
| 2020-01-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919120000357/0001209191-20-000357-index.htm |
| 2020-01-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919120004994/0001209191-20-004994-index.htm |
| 2020-01-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919120004995/0001209191-20-004995-index.htm |
| 2020-01-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919120004998/0001209191-20-004998-index.htm |
| 2020-02-03 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919120006024/0001209191-20-006024-index.htm |
| 2020-04-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919120022507/0001209191-20-022507-index.htm |
| 2020-04-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919120022516/0001209191-20-022516-index.htm |
| 2020-04-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919120022526/0001209191-20-022526-index.htm |
| 2020-04-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919120022533/0001209191-20-022533-index.htm |
| 2020-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919120036735/0001209191-20-036735-index.htm |
| 2020-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919120036737/0001209191-20-036737-index.htm |
| 2020-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919120036738/0001209191-20-036738-index.htm |
| 2020-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919120036740/0001209191-20-036740-index.htm |
| 2020-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919120036743/0001209191-20-036743-index.htm |
| 2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919120040501/0001209191-20-040501-index.htm |
| 2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919120040517/0001209191-20-040517-index.htm |
| 2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919120040524/0001209191-20-040524-index.htm |
| 2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919120040531/0001209191-20-040531-index.htm |
| 2020-08-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919120047955/0001209191-20-047955-index.htm |
| 2020-08-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919120047957/0001209191-20-047957-index.htm |
| 2020-08-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919120047959/0001209191-20-047959-index.htm |
| 2020-08-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919120047965/0001209191-20-047965-index.htm |
| 2020-08-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919120047980/0001209191-20-047980-index.htm |
| 2020-08-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919120047983/0001209191-20-047983-index.htm |
| 2020-08-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919120048126/0001209191-20-048126-index.htm |
| 2020-08-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919120048128/0001209191-20-048128-index.htm |
| 2020-08-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919120048129/0001209191-20-048129-index.htm |
| 2020-08-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919120048130/0001209191-20-048130-index.htm |
| 2020-08-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919120048132/0001209191-20-048132-index.htm |
| 2020-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919120053282/0001209191-20-053282-index.htm |
| 2020-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919120053289/0001209191-20-053289-index.htm |
| 2020-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919120053294/0001209191-20-053294-index.htm |
| 2020-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000120919120053306/0001209191-20-053306-index.htm |
| 2018-11-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1169987/000156459018028551/0001564590-18-028551-index.htm |
| 2018-11-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1169987/000156459018028575/0001564590-18-028575-index.htm |
| 2019-01-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1169987/000156459019000286/0001564590-19-000286-index.htm |
| 2019-01-18 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1169987/000156459019000786/0001564590-19-000786-index.htm |
| 2019-01-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1169987/000156459019001386/0001564590-19-001386-index.htm |
| 2019-02-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1169987/000156459019003448/0001564590-19-003448-index.htm |
| 2019-03-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1169987/000156459019006778/0001564590-19-006778-index.htm |
| 2019-03-07 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1169987/000156459019006806/0001564590-19-006806-index.htm |
| 2019-04-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1169987/000156459019010604/0001564590-19-010604-index.htm |
| 2019-04-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1169987/000156459019013707/0001564590-19-013707-index.htm |
| 2019-05-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1169987/000156459019017990/0001564590-19-017990-index.htm |
| 2019-05-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1169987/000156459019018113/0001564590-19-018113-index.htm |
| 2019-05-10 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1169987/000156459019018145/0001564590-19-018145-index.htm |
| 2019-05-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1169987/000156459019020590/0001564590-19-020590-index.htm |
| 2019-06-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1169987/000156459019022594/0001564590-19-022594-index.htm |
| 2019-07-02 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1169987/000156459019024410/0001564590-19-024410-index.htm |
| 2019-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1169987/000156459019029345/0001564590-19-029345-index.htm |
| 2019-08-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1169987/000156459019029379/0001564590-19-029379-index.htm |
| 2019-08-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1169987/000156459019032654/0001564590-19-032654-index.htm |
| 2019-10-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1169987/000156459019036515/0001564590-19-036515-index.htm |
| 2019-11-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1169987/000156459019042911/0001564590-19-042911-index.htm |
| 2019-11-12 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1169987/000156459019042942/0001564590-19-042942-index.htm |
| 2020-01-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1169987/000156459020000895/0001564590-20-000895-index.htm |
| 2020-01-17 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1169987/000156459020001334/0001564590-20-001334-index.htm |
| 2020-01-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1169987/000156459020002087/0001564590-20-002087-index.htm |
| 2020-02-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1169987/000156459020006586/0001564590-20-006586-index.htm |
| 2020-02-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1169987/000156459020007368/0001564590-20-007368-index.htm |
| 2020-03-25 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1169987/000156459020012651/0001564590-20-012651-index.htm |
| 2020-03-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1169987/000156459020012655/0001564590-20-012655-index.htm |
| 2020-03-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1169987/000156459020012724/0001564590-20-012724-index.htm |
| 2020-03-25 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1169987/000156459020012877/0001564590-20-012877-index.htm |
| 2020-03-27 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1169987/000156459020013674/0001564590-20-013674-index.htm |
| 2020-04-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1169987/000156459020015095/0001564590-20-015095-index.htm |
| 2020-04-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1169987/000156459020018215/0001564590-20-018215-index.htm |
| 2020-05-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1169987/000156459020025056/0001564590-20-025056-index.htm |
| 2020-05-13 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1169987/000156459020025064/0001564590-20-025064-index.htm |
| 2020-06-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1169987/000156459020030617/0001564590-20-030617-index.htm |
| 2020-06-26 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1169987/000156459020030864/0001564590-20-030864-index.htm |
| 2020-07-07 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1169987/000156459020031943/0001564590-20-031943-index.htm |
| 2020-07-07 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1169987/000156459020031948/0001564590-20-031948-index.htm |
| 2020-08-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1169987/000156459020039296/0001564590-20-039296-index.htm |
| 2020-08-11 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1169987/000156459020039306/0001564590-20-039306-index.htm |
| 2020-08-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1169987/000156459020040797/0001564590-20-040797-index.htm |
| 2020-08-20 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1169987/000156459020040824/0001564590-20-040824-index.htm |
| 2019-09-27 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000156761919018852/0001567619-19-018852-index.htm |
| 2020-02-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1169987/000156761920004990/0001567619-20-004990-index.htm |
| 2019-02-11 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1169987/999999999519000161/9999999995-19-000161-index.htm |
| 2019-11-26 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1169987/999999999519002672/9999999995-19-002672-index.htm |
| 2018-11-20 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1169987/999999999718009047/9999999997-18-009047-index.htm |
| 2019-03-26 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1169987/999999999719001960/9999999997-19-001960-index.htm |
| 2020-03-23 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1169987/999999999720001267/9999999997-20-001267-index.htm |
| 2020-08-03 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1169987/999999999720004261/9999999997-20-004261-index.htm |
| 2020-08-03 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1169987/999999999720004264/9999999997-20-004264-index.htm |
| 2020-08-03 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1169987/999999999720004265/9999999997-20-004265-index.htm |
| 2020-08-03 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1169987/999999999720004266/9999999997-20-004266-index.htm |
HTG Molecular Diagnostics, Inc (HTGM) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of HTG Molecular Diagnostics, Inc (HTGM). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 505%Institutional Ownership: 3314%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2020-06-10 | Shaun D McMeans | SVP, Finance & Admin. & CFO | Buy | 1,000.00 | 0.55 | 552.50 | 116,988.00 | https://www.sec.gov/Archives/edgar/data/1169987/000120919120036738/0001209191-20-036738-index.htm |
| 2019-12-10 | Shaun D McMeans | SVP, Finance & Admin. & CFO | Buy | 701.00 | 0.57 | 396.49 | 116,993.00 | https://www.sec.gov/Archives/edgar/data/1169987/000120919119060257/0001209191-19-060257-index.htm |
| 2019-06-10 | Shaun D McMeans | SVP, Finance & Admin. & CFO | Buy | 761.00 | 1.57 | 1,196.67 | 117,214.00 | https://www.sec.gov/Archives/edgar/data/1169987/000120919119036611/0001209191-19-036611-index.htm |
| 2019-08-14 | DON M HARDISON | Director | Buy | 2,500.00 | 12,500.00 | https://www.sec.gov/Archives/edgar/data/1169987/000120919119046327/0001209191-19-046327-index.htm | ||
| 2019-08-14 | JAMES T LAFRANCE | Director | Buy | 2,500.00 | 12,500.00 | https://www.sec.gov/Archives/edgar/data/1169987/000120919119046316/0001209191-19-046316-index.htm | ||
| 2019-06-10 | Laura Lee Godlewski | VP of Accounting and Reporting | Buy | 761.00 | 1.57 | 1,196.67 | 15,805.00 | https://www.sec.gov/Archives/edgar/data/1169987/000120919119036612/0001209191-19-036612-index.htm |
| 2020-06-10 | John L Lubniewski | President & CEO | Buy | 1,000.00 | 0.55 | 552.50 | 159,376.00 | https://www.sec.gov/Archives/edgar/data/1169987/000120919120036735/0001209191-20-036735-index.htm |
| 2019-12-10 | John L Lubniewski | President & CEO | Buy | 701.00 | 0.57 | 396.49 | 160,383.00 | https://www.sec.gov/Archives/edgar/data/1169987/000120919119060253/0001209191-19-060253-index.htm |
| 2019-06-10 | John L Lubniewski | President & CEO | Buy | 761.00 | 1.57 | 1,196.67 | 161,524.00 | https://www.sec.gov/Archives/edgar/data/1169987/000120919119036610/0001209191-19-036610-index.htm |
| 2019-12-10 | Laura Lee Godlewski | VP Finance, Prin Acct Offr | Buy | 701.00 | 0.57 | 396.49 | 16,506.00 | https://www.sec.gov/Archives/edgar/data/1169987/000120919119060261/0001209191-19-060261-index.htm |
| 2020-06-10 | Laura Lee Godlewski | VP Finance, Prin Acct Offr | Buy | 1,000.00 | 0.55 | 552.50 | 17,506.00 | https://www.sec.gov/Archives/edgar/data/1169987/000120919120036740/0001209191-20-036740-index.htm |
| 2019-08-14 | MICHELLE RENEE GRIFFIN | Director | Buy | 2,500.00 | 2,500.00 | https://www.sec.gov/Archives/edgar/data/1169987/000120919119046334/0001209191-19-046334-index.htm | ||
| 2019-06-10 | TIM B JOHNSON | Executive Chairman | Buy | 761.00 | 1.57 | 1,196.67 | 253,871.00 | https://www.sec.gov/Archives/edgar/data/1169987/000120919120036737/0001209191-20-036737-index.htm |
| 2019-12-10 | TIM B JOHNSON | Executive Chairman | Buy | 701.00 | 0.57 | 396.49 | 254,572.00 | https://www.sec.gov/Archives/edgar/data/1169987/000120919120036737/0001209191-20-036737-index.htm |
| 2020-06-10 | TIM B JOHNSON | Executive Chairman | Buy | 905.00 | 0.55 | 500.01 | 255,477.00 | https://www.sec.gov/Archives/edgar/data/1169987/000120919120036737/0001209191-20-036737-index.htm |
| 2019-12-26 | TIM B JOHNSON | Executive Chairman | Sell | 5,718.00 | 0.72 | 4,109.53 | 256,121.00 | https://www.sec.gov/Archives/edgar/data/1169987/000120919120000357/0001209191-20-000357-index.htm |
| 2019-05-24 | TIM B JOHNSON | Director | Buy | 7,500.00 | 2.30 | 17,250.00 | 264,601.00 | https://www.sec.gov/Archives/edgar/data/1169987/000120919119033217/0001209191-19-033217-index.htm |
| 2019-08-14 | Harry A. George | Director | Buy | 2,500.00 | 39,030.00 | https://www.sec.gov/Archives/edgar/data/1169987/000120919119046323/0001209191-19-046323-index.htm | ||
| 2020-06-10 | Byron Lawson | SVP/Chief Commercial Officer | Buy | 1,000.00 | 0.55 | 552.50 | 44,033.00 | https://www.sec.gov/Archives/edgar/data/1169987/000120919120036743/0001209191-20-036743-index.htm |
| 2019-08-14 | Lee R. McCracken | Director | Buy | 2,500.00 | 5,000.00 | https://www.sec.gov/Archives/edgar/data/1169987/000120919119046332/0001209191-19-046332-index.htm | ||
| 2019-08-14 | ANN HANHAM | Director | Buy | 2,500.00 | 7,304.00 | https://www.sec.gov/Archives/edgar/data/1169987/000120919119046320/0001209191-19-046320-index.htm |